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Comparison of the phenotypic expression of Mycoplasma gallisepticum strain R low (passage 15) to that of
strain R high (passage 164) revealed that three proteins, i.e., the cytadhesin molecule GapA, a 116-kDa protein
(p116), and a 45-kDa protein (p45), are missing in strain R high. Sequence analysis conﬁrmed that the
insertion of an adenine 105 bp downstream of the gapA translational start codon resulted in premature
termination of translation in R high. A second adenine insertion had also occurred at position 907. Restoration
of expression of wild-type gapA in R high (clone designated GT5) allowed us to evaluate the extent to which the
diminished cytadherence capacity could be attributed to GapA alone. The results indicated that GT5 attached
to the same limited extent as the parental R high, from which it was derived. The cytadherence capability of
the parental R high was not restored solely by gapA complementation alone, indicating that either p116 or p45
or both may play a role in the overall cytadherence process. The gene encoding p116 was found to be
immediately downstream of gapA in the same operon and was designated crmA. This gene exhibited striking
homology to genes encoding molecules with cytadhesin-related functions in both Mycoplasma pneumoniae and
Mycoplasma genitalium. Transcriptional analysis revealed that crmA is not transcribed in R high. We are
currently constructing a shuttle vector containing both the wild-type gapA and crmA for transformation into R
high to assess the role of CrmA in the cytadherence process.
Consistent with the interactions of typical noninvasive
pathogenic bacteria and their host cells, Mycoplasma gallisep-
ticum must ﬁrst establish a speciﬁc and ﬁrm attachment to its
target cell through a process known as cytadhesion in order to
avoid rapid clearance by innate host defense mechanisms. This
is a prerequisite for the initiation of the processes that result in
host cell alterations and pathogenesis. Recent studies on the
molecular mechanisms of M. gallisepticum cytadherence have
revealed a complex multifactorial cytadhesion process involv-
ing the coordinate action of the primary cytadhesin molecule,
GapA, while implicating additional proteins as potential cytad-
herence-related molecules in a manner reminiscent of the
complex cytadherence mechanism of the human respiratory
pathogen Mycoplasma pneumoniae. M. pneumoniae cytadher-
ence has been demonstrated to involve the coordinate action
of the primary cytadhesin molecule, P1 (11, 12, 21), in concert
with an array of high-molecular-weight accessory proteins (7,
8). Prolonged colonization and survival of M. gallisepticum in
the host requires maximal utilization of cytadhesin molecules
in association with the cytadherence-related molecules. This
ultimately confers a selective advantage for that strain of
pathogenic M. gallisepticum over those with diminished cytad-
herence capacity. The aim of this study was to characterize the
molecular basis for the diminished cytadherence capacity as
well as to investigate the biochemical and molecular properties
of the molecules observed to be involved in the phenotypic
alterations in the avirulent R high strain.
MATERIALS AND METHODS
Organisms and culture conditions. M. gallisepticum strains R low (passage 15)
and R high (passage 164) (gifts from Sharon Levisohn, Department of Food
Animal and Equine Medicine, College of Veterinary Medicine and Poultry
Diseases, North Carolina State University, Raleigh) were cultured in Frey’s
medium (3) at 37°C until mid-logarithmic phase was achieved. Escherichia coli
INVaF9 (Invitrogen, Carlsbad, Calif.) and E. coli XL1-Blue competent cells were
grown in Luria broth (10 g of tryptone,5go fyeast extract, and5go fNaCl per
liter) and on Luria plates at 37°C.
SDS-PAGE and amino acid analysis. Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) was performed according to the protocol de-
scribed by Laemmli (15). Triton X-114 (TX-114) phase partitioning was per-
formed according to the method of Bordier (1). Proteins that were identiﬁed as
differentially expressed were excised and electroeluted from a polyacrylamide gel
using a Bio-Rad electroelution unit. The eluted proteins were run into SDS–10%
polyacrylamide gels and then subjected to in-gel digestion with Lys-C protease,
followed by sequence analysis according to the procedure of Edman and Begg
(2).
Immunoblot analysis. Western blots of R low, R high, and GT5 SDS-PAGE-
separated proteins were transferred to BA-S85 nitrocellulose (Schleicher &
Schuell, Inc., Keene, N.H.) according to the protocol described by Towbin et al.
(22). For colony immunoblots, nitrocellulose membranes (82-mm diameter and
0.45-mm pore size) were placed onto M. gallisepticum colonies grown on agar
plates as described by Goh et al. (6). All membranes were blocked with 5%
bovine serum albumin in phosphate-buffered saline (PBS) at 4°C overnight and
washed three times with PBS-Tween. The membranes were reacted with rabbit
anti-GapA serum at a dilution of 1:8,000, incubated for1ha t37°C with gentle
rocking, and washed three times with PBS-Tween. Peroxidase-conjugated goat
anti-rabbit immunoglobulin G (heavy plus light chains) (Sigma, St. Louis, Mo.)
was added at a ﬁnal concentration of 1:7,500, and the membranes were incubated
at room temperature for 1 h with gentle rocking. The membranes were washed
three times with PBS, and the reaction products were visualized by the addition
of 4-chloro-1-naphthol in the presence of hydrogen peroxide.
Nucleic acid extractions. R low (passage 15), R high (passage 164), and GT5
genomic DNAs were extracted according to the method of Hempstead (9), and
total RNAs were extracted from 30 ml of mid-logarithmic-phase culture accord-
ing to the hot-phenol extraction protocol described by Sambrook et al. (19) The
concentrations and purities were determined spectrophotometrically using ab-
sorbance measurements at 260 nm and ratios of absorbance measurements at
260 and 280 nm, respectively (19). Plasmid DNAs were extracted using either the
Qiagen Plasmid Midi kit protocol as described by the manufacturer (Qiagen,
Inc., Santa Clarita, Calif.) or miniplasmid preparations according to the protocol
described by Holmes and Quigley (10).
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6643PCR and RT-PCR. PCRs were performed in a total volume of 50 ml containing
50 ng of template; a 250 mM concentration each of dATP, dTTP, dGTP, and
dCTP; 1.5 mM MgCl2; 400 ng of each primer (synthesized by the University of
Connecticut Biotechnology Center); and 2.5 U of AmpliTaq (Applied Biosystem/
Perkin Elmer, Norwalk, Conn.) The targeted regions were ampliﬁed under the
following conditions: 25 cycles of 94°C for 1 min, 5°C below the melting tem-
perature of the primer for 1 min, and 72°C for 2 min, followed by 1 cycle at 72°C
for 10 min.
The GeneAmp RNA PCR kit (Perkin-Elmer Roche, Branchburg, N.J.) was
used to generate R low and R high cDNAs. Reverse transcriptase PCRs (RT-
PCRs) were performed in a total volume of 20 ml containing 5 mM MgCl2;a
1mM concentration each of dATP, dCTP, dTTP, and dGTP;1Uo fRNase
inhibitor (1 U/ml); of 2.5 U of murine leukemia virus reverse transcriptase (2.5
U/ml); 2.5 mM random hexamers and 1 mg template. A Perkin-Elmer model 480
thermal cycler was used, and the reactions proceeded under the following con-
ditions: one cycle of 42°C for 15 min, 99°C for 5 min, and 5°C for 5 min.
Subsequent PCR ampliﬁcations of the respective cDNAs were performed as
described above. The primer pairs utilized are described in Table 1.
Cloning and transformation. PCR products were cloned into the PCRII vector
of the TA cloning kit according to the protocol of the manufacturer (Invitrogen).
The vectors containing the correct inserts were transformed into E. coli INVaF9
(Invitrogen) competent cells according to the manufacturer’s protocol. White
colonies were selected and the inserts were sequenced, as described below.
Plasmid, pISM2062, containing the modiﬁed transposon Tn4001mod (14), was
used as the vector to insert wild-type gapA into a GapA
2 clonal isolate of R high.
The R high culture used for transformations was reconﬁrmed to be negative for
gapA expression by immunoblotting immediately prior to use. A 4,112-bp frag-
ment containing the gapA gene was ampliﬁed from M. gallisepticum strain R low
using forward (59 GGGGGATCCAGACCAAACTTCCCTAAC 39) and reverse
(59 GGGGGATCCAGCAAAATCATCACTTAG 39) primers. Tn4001mod con-
tains a unique BamHI site at the end of the IS256L arm (7, 14). The fragment
containing the gapA gene was cloned into the BamHI site of the Tn400lmod.
Recombinant clones were selected with the insert oriented so that gapA was
transcribed from an outward-reading promoter in IS256L. R high was trans-
formed by a modiﬁcation of the method of King and Dybvig (13). Brieﬂy,
organisms from 1 ml of overnight culture were harvested and washed in ST buffer
(500 mM sucrose, 10 mM Tris [pH 6.5]). Washed cells were suspended in 500 ml
of 100 mM CaCl2 and incubated on ice for 30 min. Yeast RNA (20 mg) and the
Tn4001-gapA vector DNA (10 mg) were added along with 4 ml of 40% polyeth-
ylene glycol, and the suspension was incubated for 2 min at room temperature.
The suspension was diluted with 20 ml of ST buffer, and the cells were harvested
by centrifugation at 10,000 3 g for 15 min. The cell pellet was suspended in 2 ml
of Frey’s medium (3) and incubated at 37°C for 3 h. After incubation, 50 mgo f
gentamicin ml
21 was added, and the broth cultures were incubated at 37°C
overnight, plated on solid medium containing 15 mg of gentamicin ml
21, and
incubated further at 37°C. Single colonies were picked, propagated, analyzed by
immunoblotting, using anti-GapA serum, for the expression of gapA and by
Southern hybridization (20) of HindIII-digested genomic DNA using both
32P-
labeled gapA as a probe, and then reprobed with
32P-labeled Tn4001 DNA. The
Southern hybridization conditions were as follows. Probes were incubated with
the blot (42°C with 45% [vol/vol] formamide) for 16 h. Filters were washed twice
with 23 SSC (300 mM NaCl, 30 mM sodium citrate, pH 7.0)–0.1% SDS and
O.23 SSC–0.1% SDS for 3 min at room temperature, followed by two additional
washes at 50°C in 0.163 SSC–0.1% SDS for 15 min. The ﬁlters were dried and
exposed to ﬁlm (Fuji Rx ﬁlm; Fisher Scientiﬁc, Pittsburgh, Pa.) using intensifying
screens. Those clones which were positive for GapA by immunoblotting and
possessed the complemented wild-type copy of the gapA were analyzed further.
The restriction fragment containing the Tn4001-gapA insert was excised and
cloned into pBluescript SK11(1) (Stratagene), which had been previously di-
gested with HindIII and treated with calf intestinal alkaline phosphatase, at a 2:1
insert DNA-to-vector ratio. The ligation mixture was transformed into E. coli
XL1-Blue competent cells (19) and selected for on Luria broth plates containing
100 mg of ampicillin ml
21 and 25 mg of X-Gal (5-bromo-4-chloro-3-indolyl-b-D-
galacto-pyranoside) ml
21. The DNA sequence was determined as described
below (using oligonucleotide primers synthesized from the ends of the insertion
sequence element and primer walking).
DNA sequencing. Sequencing was accomplished by primer walking and was
performed at the Keck Foundation Biotechnology Resource Laboratory at the
Yale University School of Medicine in New Haven, Conn., and at the University
of Connecticut Macromolecular Characterization Facility of the Biotechnology
Center. DNA sequencing reactions were performed using a Taq DyeDeoxy
Terminator Cycle Sequencing Kit according to the protocol of the manufacturer
TABLE 1. Primer pairs used to amplify gapA and crmA from M. gallisepticum
Gene or procedure Amplicon Size (bp) Primers Position
a
gapA A 1,008 59 AGA CCA AAC TTC CCT AAC 39 (forward) 1–1008
59 CCT CCT CCA GCA GCA CTA 39 (reverse)
B 462 59 GCC GGA TTG ATT TGT ATG 39 (forward) 644–1105
59 CAG AAG TAG AAG CAG TAG GA 39 (reverse)
C 725 59 TGA TAA TCC TAA TGC TGT 39 (forward) 1447–2171
59 ACT TGT TTT GTG TTT CC 39 (reverse)
B9/C 1,511 59 GCC GGA TTG ATT TGT ATG 39 (forward) 661–2171
59 ACT TGT TTT GTG TTT CC 39(reverse)
D 1,135 59 ATT AGT AAG CCA GCT GGT 39 (forward) 2137–3471
59 CTT ACG GTT TTG AGA CAT TG 39 (reverse)
E 1,050 59 TAA TGT AAT CGG TCA AGG TGC 39 (forward) 3042–4091
59 CCA GCA AAA TCA TCA CTT AG 39 (reverse)
crmA F 1,507 59 CTA AGT GAT GAT TTT GCT GG 39 (forward) 4071–5577
59 ARR TAR TTD CCC ATD GCD GG 39 (reverse)
G 850 59 CAA GAG TAG GTA CTG AAA CC 39 (forward) 5510–6359
59 SWY TGR TTW GTW ACR AA 39 (reverse)
H 2,024 59 GTG GCT AGA AAC TTC GTT ACA 39 (forward) 6331–8354
59 CKR TTY TCR TCN GTY CRT T 39 (reverse)
RT-PCR I 462 59 GCC GGA TTG ATT TGT ATG 39 (forward) 644–1105
59 CAG AAG TAG AAG CAG TAG GA 39 (reverse)
J 350 59 TAA GAA GAC TCC ACA AAT GCT 39 (forward) 3579–3928
59 TAG CAT CTA GCG TTC TTG CTT G 39 (reverse)
a Positions refer to locations in gapA or crmA.
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sequencer. DNAMAN (Lynnon BioSoft, Quebec, Canada) was used for the
alignments of the amino acids. The stem-loop structures were determined using
DNAMAN and MacDNASIS (Hitachi Software Engineering America, San
Bruno, Calif.).
Pulse-chase analysis. Pulse-chase analysis of R low and R high was performed
by the method of Popham et al. (18) at both 37 and 4°C. The cells were then
subjected to TX-114 phase partitioning, and the proteins were electrophoresed
in a 10% polyacrylamide gel. They were transferred to BA-S85 nitrocellulose
(Schleicher & Schuell, Inc.) and then dried and exposed to X-ray ﬁlm (Fuji Rx
ﬁlm; Fisher Scientiﬁc) at 270°C for 48 h. Following autoradiographic analysis,
the membranes were immunoblotted with anti-GapA serum as described above.
Cytadherence assay. MRC-5 cell culture cytadherence assessments were per-
formed as previously described (4, 5) using tritium-labeled M. gallisepticum R
low, R high, and GT5.
Nucleotide sequence accession number. The GenBank accession number for
the sequence reported in this paper is AF214004.
RESULTS
Comparative analysis of R low and R high. The analysis of
both R low and R high following TX-114 phase partitioning
and SDS-PAGE is shown in Fig. 1. GapA (lane 6) is missing
from R high, as are two additional proteins; one in the insol-
uble phase with a molecular mass of 116 kDa (lane 6) and the
other in the detergent phase with a molecular mass of 45 kDa
(lane 8). These proteins are designated p116 and p45, respec-
tively. The three proteins were isolated from R low and sub-
jected to amino acid analysis after in-gel digestion with Lys-C
protease to generate internal amino acid data (2). A peak
from the suspected GapA protein was sequenced, resulting in
10 amino acids. This sequence was found to be 100% identical
to our published GapA sequence (GenBank accession no.
U44804). Western blot analysis (22) utilizing anti-GapA serum
(Fig. 2A) resulted in a positive reaction in R low but not in R
high. These data veriﬁed the identity of this protein (which is
absent from R high) as GapA. Additionally, they indicated that
the lack of expression is not a consequence of size variation or
stable truncation of GapA, since no size variant was recog-
nized. Southern blot analysis (20) was performed on both R
low and R high to determine if the gapA gene was present in R
high. The results indicated that the gene is present in both.
RT-PCR ampliﬁcation of gapA indicated that the gapA gene is
also transcribed in both strains (Fig. 2C).
The results of pulse-chase experiments at both 37 and 4°C
indicated that gapA was expressed in R low but was not ex-
pressed in R high. Identical pulse-chase experiments followed
by immunoblot analysis using anti-GapA serum conﬁrmed that
gapA is expressed in R low but not in R high, and no lower-
molecular-mass products were detected (data not shown).
Comparative analysis of the DNA sequences of gapA from R
low and R high revealed the insertion of an adenine 105 bp
downstream of the translational start site of gapA in R high,
resulting in a premature translational stop signal (TAA) (Fig.
2B). Insertion of a second adenine was also found at base 907,
resulting in a second TAA codon.
MRC-5 cell culture attachment tests comparing the cytad-
herence capabilities of R low and R high indicated that R high
attached with only 24% of the efﬁciency of R low (data not
shown).
Complementation of R high with wild-type gapA. Figure 3A
shows the results of anti-GapA immunoblot analysis of R high
after transformation with pISM2062 containing the modiﬁed
transposon Tn4001-gapA (pUCGgapA). All clones expressed
gapA but not to wild-type levels. As shown in Fig. 3B, Southern
hybridization of HindIII-digested genomic DNAs from these
clones probed with
32P-labeled gapA resulted in hybridization
with both the genomic, mutant gapA and the inserted copy of
the wild-type gapA in each of the clones. The clone in lane 5
(designated GT5) was selected for further analysis.
Colony immunoblotting of GT5 reacted with anti-GapA se-
rum (data not shown) indicated that GapA was presented on
the surface.
The results of cytadherence analysis indicated that GT5 at-
tached to the same limited extent as the parental R high, from
which it was derived (data not shown). The cytadherence ca-
FIG. 1. SDS-PAGE of M. gallisepticum strains R low and R high. Lanes 1 and 2, total protein proﬁles of R high (lane 1) and R low (lane 2). Lanes 3 to 8, detergent,
aqueous, or insoluble phase obtained following TX-114 phase partitioning, as follows: lane 3, R high, aqueous; lane 4) R low, aqueous; 5, R high, insoluble; 6, R low,
insoluble; 7, R high, detergent; 8, R low, detergent. The arrows point to proteins present in R low but missing in R high. The molecular mass markers are represented
in kilodaltons.
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insertion and expression of gapA alone.
The RT-PCR results using primers designed from the se-
quence of a suspected open reading frame (ORF) 59 of the
insertion site showed no ampliﬁcation product. A BLAST
search of the DNA sequence as well as negative RT-PCR
results indicated that Tn4001-gapA did not insert into a tran-
scribed ORF in GT5.
CrmA analysis. Three peaks (8 to 10 amino acids each) from
p45 and from p116 were also sequenced. One of the three
amino acid peaks (FVIGGVPS) obtained from p116 matched
with the translated product of our partial sequence of ORF 3
immediately downstream of gapA. Anchor PCR ampliﬁcation
employing a speciﬁc primer within the downstream sequence
ﬂanking gapA and the degenerate primer, designed from the
amino acid sequence (VLTYPVMGGYLT) from a second
FIG. 2. Analysis of the gapA operon. (A) Western blot of R low and R high reacted with anti-GapA serum. The molecular mass markers are represented in
kilodaltons. (B) Adenine insertion sites at positions 105 and 907 in gapA of R high generating TAA termination codons. (C)RT-PCR analysis utilizing primer pairs I
and J in R high and R low. (D) Stem-loop structures found downstream of the TAA stop codon at positions 120 and 326.
FIG. 3. Immunoblot and Southern hybridization analyses of M. gallisepticum R high clones transformed with Tn4001-gapA. (A) Anti-GapA immunoblot analysis.
Lanes: 1, R high; 2, R low; 3 to 8, R high clones transformed with Tn4001-gapA. The molecular mass markers are represented in kilodaltons. The asterisk indicates
clone GT5. (B) Southern blot analysis of HindIII-digested total genomic DNAs probed with
32P-labeled gapA. Lanes: 1, R high; 2, R low; 3 to 8, R high clones
transformed with Tn4001-gapA. Molecular size markers are in kilobase pairs.
6646 PAPAZISI ET AL. INFECT.I MMUN.peak of p116, resulted in an 1.5-kbp amplicon. A second PCR
ampliﬁcation using primer pair G (Table 1) resulted in an
850-bp fragment. The remainder of the gene was obtained
using primer pair H (Table 1), resulting in a 2-kb ampliﬁed
product. The entire ORF was sequenced and found to be a
3.2-kb gene encoding a 116-kDa protein (designated CrmA
[for cytadherence-related molecule A]). Comparison of crmA
sequences from R high and R low showed them to be identical.
RT-PCR analysis of the crmA gene indicated that it is not
transcribed in R high (Fig. 2C). Sequence comparisons re-
vealed 41% overall amino acid identity with M. pneumoniae
ORF 6 and MgpC of Mycoplasma genitalium. Hydrophobicity
proﬁles and protein sequence analysis showed a striking ho-
mology among the last 250 amino acids of the C termini of
these three proteins. These regions (Fig. 4) appear to be di-
vided into two domains. The ﬁrst domain (A) represents a
surface-exposed region and is shared among cytadhesin-re-
lated molecules M. gallisepticum CrmA, M. pneumoniae ORF
6, and M. genitalium MgpC, with an overall 55% amino acid
identity. The second domain (B) represents the transmem-
brane region and intracytoplasmic tail and is common not only
among these three proteins (overall amino acid identity, 63%)
but also among other mycoplasma adhesins (M. gallisepticum
GapA, M. pneumoniae P1, M. genitalium MgPa [MYCGE-
FIG. 4. Amino acid domains shared among mycoplasma cytadhesins and cytadhesin-related molecules. Domain A reveals 55% shared amino acid identity among
the cytadhesin-related molecules M. gallisepticum CrmA, M. pneumoniae MgpC (ORF 6), and M. genitalium MgpC. Domain B reveals 63% shared amino acid identity
among the cytadhesin-related molecules stated above and 51% identity overall, including the cytadhesins M. gallisepticum GapA, M. pneumoniae P1 (ADP1), M.
genitalium MgPa (ADP1), and the P1-like adhesin of M. pirum.
VOL. 68, 2000 CYTADHERENCE-DEFICIENT MYCOPLASMA GALLISEPTICUM 6647ADP1], and M. pirum P1-like adhesin). The overall amino acid
identity among all seven of these proteins in this domain is 49%.
DISCUSSION
The high-passage R strain (R high) is a laboratory attenu-
ated strain that resulted from multiple successive passages of
the virulent R low in medium. It has previously been demon-
strated (17) that R low is pathogenic for chickens, colonizing
the trachea in in vivo assays and producing air sac and tracheal
lesions. In contrast, R high required 4 orders of magnitude
more organisms to colonize air sacs and tracheas yet produced
no detectable lesions. The attenuation(s) which occurred di-
minished the organism’s ability to adhere and to colonize in
vivo. The molecular and biochemical nature of the attenua-
tion(s) has not been evaluated until now. Our investigations
have focused on the elucidation of the molecular basis for the
diminished cytadherence and pathogenesis of R high. R high
does not express the genes encoding three proteins, i.e., the
cytadhesin molecule GapA, p116, and p45, which are ex-
pressed in R low. TX-114 phase partitioning and immunoblot
analysis indicated that gapA was expressed in R low but was not
expressed in R high. Pulse-chase experiments followed by im-
munoblot analysis using anti-GapA serum conﬁrmed that gapA
is expressed in R low but not in R high. RT-PCR results
showed that gapA is transcribed in both strains. Comparative
DNA sequence analysis of gapA from R low and from R high
revealed that gapA is not expressed in R high due to the
insertion of a single adenine at position 105, creating a stop
codon and thereby resulting in a premature termination of
translation. If a truncated protein was expressed, it would
therefore measure approximately 4 kDa. No protein of this
molecular mass was detected, indicating that a truncated pro-
tein (if expressed) was unstable and therefore immediately
degraded.
In vitro assays comparing the cytadherence capabilities of R
low and R high indicated that R high attached with only 24%
of the efﬁciency of R low. The in vitro cell culture assay elim-
inates the innate host defense mechanisms, such as coughing
and ciliary motility, which are further impediments to success-
ful colonization by M. gallisepticum. Therefore, a greater num-
ber of organisms may adhere in the in vitro assay that might
otherwise be swept away following exposure in the host animal.
This likely accounts for the discrepancy noted between the
number of R high organisms required for colonization in the
host and the number that adhere in the cell culture assay.
Restoration of expression of wild-type gapA in R high (GT5)
allowed us to evaluate the extent to which the diminished
cytadherence capacity could be attributed to GapA alone. Col-
ony immunoblotting of clone GT5 reacted with anti-GapA
serum indicated that GapA was exposed on the surface. It was
essential for subsequent cytadherence analysis to be certain
that GapA was exposed on the surface of the organism, thus
allowing for proper interaction with its corresponding host cell
receptor. The results of the in vitro cytadherence analysis in-
dicated that clone GT5 attached to the same limited extent as
the parental R high, from which it was derived. The cytadher-
ence capability of the parental R high was not restored solely
by the insertion and expression of gapA alone. The Tn4001-
gapA insertion site in clone GT5 was then analyzed to deter-
mine whether or not the Tn4001-gapA inserted into a tran-
scribed ORF which might encode a protein of yet-unknown
function that might affect cytadherence. The sequence and
RT-PCR analyses indicated that Tn4001-gapA did not insert
into a transcribed ORF in clone GT5. These data suggested
that one or both of the other proteins, p116 and/or p45, which
are missing from R high, may play a role either in the presen-
tation and localization of GapA or in some other cytadher-
ence-related molecule functional capacity.
Amino acid sequence data from the peptide fragments from
p116 allowed us to design degenerate oligonucleotide primers.
These were then used in PCRs to obtain a partial DNA se-
quence and ultimately to identify the entire gene encoding
p116. This gene, designated crmA, was determined to be im-
mediately downstream of gapA (previously referred to as ORF
3) in the operon (6). The DNA sequence of crmA is identical
in both R low and R high, while RT-PCR analysis demon-
strated that crmA is transcribed in R low but not in R high.
Lack of crmA transcription in R high is likely a consequence of
the premature termination of translation of gapA upstream
and of the stem-loop structures found 15 bp (DG 25.3 kcal)
and 221 bp (DG 29.9 kcal) downstream of the TAA codon
(Fig. 2D). The high degree of amino acid sequence identity
exhibited by CrmA to ORF 6 of M. pneumoniae and to MgpC
of M. genitalium suggests a functional conservation among
molecules associated with and essential for effective cytadher-
ence in these pathogenic mycoplasmas. ORF 6 of M. pneu-
moniae encodes a 130-kDa protein which is cleaved into a 90-
and 40-kDa proteins which have been shown to be cytadher-
ence-associated membrane proteins involved in tip structure
formation (16).
The gene encoding the 45-kDa protein is not a part of the
gapA operon and has not been fully characterized at this
time, but it is a subject of our continuing investigation.
We are currently constructing a Tn4001-gapA/crmA vector
(pUCGgapA/crmA) for the purpose of transformation into R
high to assess the degree of restoration of cytadherence capa-
bility. This will also provide valuable insights into the interac-
tion of CrmA and GapA and the overall cytadherence process.
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